Steroid Detection Times and Drug Testing

Detection time vs half-life: two different numbers

A compound's half-life describes the time required for its blood concentration to drop by half. It governs the duration of biological effect and the timing of PCT (post-cycle therapy). Detection time, on the other hand, depends on the sensitivity of analytical methods: a metabolite excreted at vanishingly low concentrations can remain identifiable long after blood levels have dropped to background ^[2]. The half-life calculator is for planning cycles and PCT; it says nothing about anti-doping detection windows.

The role of the ester

For injectable steroids, it is the parent molecule (testosterone, nandrolone, trenbolone, etc.) that gets detected through its metabolites — not the ester itself. A long ester nonetheless stretches the detection window, simply because it prolongs the release of the active molecule: testosterone propionate has a shorter detection time than testosterone enanthate, not because the testosterone is different, but because it keeps being released for longer in the second case.

Table — injectable steroids

Indicative values, drawn from AnaProtoKol molecule pages (the detectionTime field). Variations depend on lab sensitivity, dose, and duration of use.

Table — oral steroids

The trickiest case among orals is turinabol: its short biological half-life (16 hours) contrasts with a detection window in the order of 12 months, inherited from long-lasting metabolites identified by modern methods. That is the window on which many athletes were retroactively flagged years after use (notably the 2008 and 2012 Olympic sample reanalyses) ^[1].

Table — SARMs, peptides, and others

The WADA framework: in-competition and out-of-competition

WADA (the World Anti-Doping Agency) publishes the global Prohibited List every year. All international sports federations and national agencies adhere to it — USADA in the US, UKAD in the UK, CCES in Canada, ASADA / Sport Integrity Australia, NADO Italia in Italy, NADA in Germany, AFLD in France. The list draws a sharp line between two testing contexts.

In-competition

In-competition testing covers substances banned 'in-competition' — which includes anabolic steroids, SARMs, growth factors, peptides, diuretics and masking agents, but also stimulants (high-dose caffeine, ephedrine, clenbuterol), cannabinoids, and narcotics. The in-competition window generally starts the day before the event and ends after the event concludes.

Out-of-competition

Out-of-competition testing (no-notice, at home, at training camp) covers only substances banned at all times — essentially anabolic steroids, SARMs, peptide hormones (HGH, IGF, gonadotropins), hormone manipulators (anti-estrogens, AIs, SERMs), and banned methods (transfusion, gene manipulation). This is where the long detection windows (nandrolone decanoate, turinabol) become decisive — an athlete can test positive months after a cycle.

Practical stakes for athletes who face testing

For a non-competitor (or a competitor in a non-tested federation — open powerlifting, untested bodybuilding, untested strongman), detection time has no practical stake. For anyone licensed in a federation affiliated with WADA, or potentially subject to testing (national-level tested powerlifting, track and field, cycling, swimming, professional MMA, NCAA athletics, Olympic-track sports), the tables above become decisive in compound selection.

Consequences for compound choice

• Avoid compounds with very long detection windows (nandrolone decanoate, turinabol).
• Favor short esters that clear quickly after the last injection.
• Plan PCT plus a multi-month "clean" window before any tested competition.
• Understand that peptides and MK-677, not routinely tested, are still not 'allowed' compounds: their use remains classified as doping and is liable to sanction if detected by a dedicated method.

Frequently asked questions